Mydecine Innovations Group, Inc. (TSE:MYCO) has released an update.
Mydecine Innovations Group Inc. has requested a Management Cease Trade Order to allow additional time to finalize their 2023 financial statements and accompanying documents, which were delayed due to a restatement of prior financials and an auditor change. The company expects to complete the filings by June 28, 2024, and will issue bi-weekly status reports until the filings are complete, while adhering to a trading blackout and alternative reporting guidelines.
For further insights into TSE:MYCO stock, check out TipRanks’ Stock Analysis page.
